Nvidia invests $50 million into Recursion for drug AIĀ
Drug Discovery World
JULY 13, 2023
Recursion, a clinical stage company decoding biology to industrialise drug discovery, has announced a $50 million investment by NVIDIA, which was executed as a private investment in public equity (PIPE).
Let's personalize your content